No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Cardiovascular Diseases / drug therapy
-
Chronic Disease / therapy*
-
Comorbidity*
-
Comparative Effectiveness Research
-
Education, Medical, Continuing*
-
Geography
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
Myocardial Infarction / drug therapy
-
Practice Guidelines as Topic
-
Primary Health Care*
-
Pulmonary Disease, Chronic Obstructive
-
United States
-
United States Agency for Healthcare Research and Quality*
Substances
-
Adrenergic beta-Antagonists
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors